November 2009 Archives
Here at Edelman, we are all looking forward to the upcoming public hearing that the FDA is holding on social media.
Read More
Post CommentPermalink
Comments (1)
Save on Del.icio.us
Digg this
Google Bookmarks
My Yahoo
Facebook
Several of the presenters for next week's FDA Hearing have provided their content online for the public to see.
Some of the biggest names in the Australian pharmaceutical industry attended the Edelman Health breakfast, The Changing Media Landscape, with Edelman’s Asia-Pacific President Alan VanderMolen and guest speakers; Roche digital capabilities manager, Arthur Alston; and editor of 6Minutes, Michael Woodhead....
First, Do No Harm
“Fair balance” in medical product communications in the age of public engagement
posted by Nancy Turett on Nov 10, 2009
posted by Nancy Turett on Nov 10, 2009
he very fact that the US government is examining the regulatory framework for how companies engage with the public through social media speaks to the explosive, revolutionary impact of the age of public engagement:
Government leaders and their advisors see that the health engagement train has left the station -- gliding, twisting and turning on ever-crossing, infinite tracks of the Internet, and that all participants in society need to collaborate with engineers of the train. As Newsweek’s Jacob Weisberg articulates in his Nov 9 column, “In a world where everyone has his own printing press, restrictions on personal behavior will become increasingly untenable.”
My Washington colleague Jenna Kozel discusses the FDA social media hearing and the pharmaceutical industry’s role in public/private social media engagement. Jenna is an account supervisor on the DC Digital Public Affairs team.
If you’ve seen MyParentsJoinedFacebook.com, you’ll understand that not everyone meshes with the network, ethos and language of the community a person creates for herself on Facebook. Parents have a funny way of responding to things they shouldn’t and in ways that don’t make sense. Is the world reacting to pharmaceutical companies the same way as kids react to their parents joining Facebook?
The FDA public hearing on regulated medical products using the internet and social media began this morning.
Heather Harper, who works with companies bringing innovations and resources to the e-patient community, gives some perspective from the patient community and highlights the benefits already being seen from widespread access to health information and engagement.
There’s no denying it, the e-patient revolution has begun. And that movement sets an important context for tomorrow’s FDA hearings on social media usage by medical products manufacturers. As we digest the discussion and many interested people offer additional comments to the FDA, we must make sure we are informed by the robust patient-driven conversation that is already raging online.
Tags:
e-patient
FDA health hearings
In a move many are calling long-overdue, the FDA’s social media hearing (formally: Public Hearing on Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools) commenced today. The purpose of this two-day session is for interested parties to comment on Internet and social media promotion of prescription drugs and vaccines. Currently, there is little industry guidance around this topic.
This guest post is from Dave Levy (@levydr) from Edelman’s Digital Public Affairs team in Washington, D.C. Disclosure: Wave was created by Google, a competitor of Edelman's client Microsoft The first day of the FDA Hearing on Social Media is...
The FDA’s social media hearing concluded today with a second round of testimony on the challenges surrounding online promotion of health information. The morning session focused on adverse event (AE) reporting, while the afternoon session supplemented yesterday’s discussion of manufacturer accountability, real-time information, corrective information, and use of links. (Our Day 1 summary is available here.) Yesterday’s hearing received significant media coverage and we expect the same for today’s panels.
Today is Prematurity Awareness Day. Unfortunately, the March of Dimes recently released its second annual Premature Birth Report Card and America scored a depressing “D.” What that means is that every year, we’re failing more than half a million babies....
Following last week's FDA hearings, we know we probably won't hear guidance from the FDA for a year or so. In the interim, we must continue to rely on past experience, existing DDMAC guidance, and what we heard from those...
Edelman Australia with Reckitt Benckiser won the award for the best PR initiative at the Australian Self Medication Industry Awards on 12 November for the Manage Pain – effectively, safely, responsibly pharmacy education campaign. The Manage Pain campaign was developed...
This WSJ article, despite its focus on US health reform, offers evidence that health is mighty personal. The leaders of three top global health enterprises (Cosgrove of Cleveland Clinic; Vasella of Novartis; and Williams of Aetna) provide commentary that the...
Health Engagement Barometer Report - Download PDF
Health Engagement Barometer Study - Download Deck
Audio From Barometer Launch Presentation
Posts RSS
Subscribe to Engage in Health by E-mail
Press Release
News Feed:
Edelman Widget
@engageinhealth
Blog Roll:
- Diabetes Mine
- The Health 2.0 Blog
- The Health Care Blog
- Health Care Law Blog
- HealthCareVox
- Health Populi
- Health Wonk Review
- On Social Marketing & Social Change
- Pharma Marketing Blog
- Well Blog
- WSJ.com Health Blog
- Health Beat
- KevinMD
- New England Journal of Medicine
- New Health Dialogue
- WSJ Health
- whydot pharma
Archive:
©2009 Edelman
